Mark your Calendars for Targeting Phage Therapy 2025
The Scientific Committee published the first Agenda of the 8th World Conference on Targeting Phage Therapy, which will be held on June 10-11, 2025, at DoubleTree by Hilton Berlin Kudamm, Berlin, Germany. Read More
Concluding Remarks by Prof. Dr. Christian Willy
Prof. Dr. Christian Willy from the Military Academic Hospital Bundeswehr Berlin, Germany, will give concluding remarks and deliver his vision on How phage therapy may evolve in the coming years.
Speakers Lineup 2025
Keynote Speech – Phage Therapy 2030: Getting from here to there
Robert T. SchooleyUniversity of California, San Diego, USA
Bacteriophage Therapy: A Renaissance – From Military Medicine to Civilian Healthcare
Christian WillyMilitary Academic Hospital Bundeswehr Berlin, Germany
Complex Phage Communities Control Gut (im)balances and May Hold the Key to Restore Gut Biosis
Dennis Sandris NielsenUniversity of Copenhagen, Denmark
Inhaled Bacteriophage Therapy for Multidrug Resistant Pseudomonas Aeruginosa: Advances & Perspectives
Gail L. StanleyYale University, USA
KlebPhaCol: Novel Gut Phage Order Associated with the Human Gut
Franklin NobregaUniversity of Southampton, United Kingdom
Optimizing the Phage-Bacteria Ratio in Phage Therapy: Metagenomic Insights into Microbial Balance and Dysbiosis
Domenico FrezzaUniversity of Roma Tor Vergata, Italy
Phage Defense Systems: Are they an Obstacle for Phage Therapy?
Stan J.J. BrounsDelft University of Technology, The Netherlands
Biocontrol of Phage Resistance in Pseudomonas Infections – Fitness Trade-Offs Between Phages and Antibiotic Sensitivity
Jumpei FujikiRakuno Gakuen University, Japan
Yersinia Phage Stories: Impact on Phage Therapy
Mikael SkurnikUniversity of Helsinki, Finland
Targeting Tumors with Engineered Phages: A New Frontier in Precision Oncology
Alberto DanielliUniversity of Bologna, Italy
Engineering Phages for Cancer Therapy: Insights into Immune Interactions and Targeting in Ex-Vivo and In-Vivo Models
Alena KaltenbrunnerUniversity of Bologna, Italy
Endolysin B as a New Approach & Archetype in M. Tuberculosis Treatment
Loris RizzelloUniversity of Milan, Italy
Ex vivo pig lung as a new Cystic Fibrosis model for the study of Pseudomonas aeruginosa biofilm infection and phage therapy application
Marco CaforaUniversity of Milan, Italy
Translating Phage Therapy into the Clinic: Recent Accomplishments and Next Challenges
Jeremy BarrMonash University, Australia
Bacteriophage Therapy for Critical Infections Related to Cardiothoracic Surgery
Christian KühnHannover Medical School, Germany
Phage Therapy in Veterinary Medicine: Presentation of First Clinical Trial in Japan
Hidetomo IwanoRakuno Gakuen University, Japan
Bacteriophages Applications in Broiler Farms: Strategies & Perspectives
Sandra Sevilla-NavarroCentro de Calidad Avícola y Alimentación Animal de la Comunidad Valenciana, Spain
Phage Therapy in Europe: Legal, Regulatory and Ethic Issues
Barbara BrennerKanzlei BRENNER, Germany
CellMaker- The Ideal Solution for Scalable Phage Manufacturing
Ruta TeterovskaCellexus International Ltd, United Kingdom
The Targeting Phage Therapy 2025 Abstract Book is the official scientific publication of the 8th World Conference on Targeting Phage Therapy, held June 10–11, 2025, in Berlin. This comprehensive volume includes over 75 contributions from global experts, including keynote lectures, clinical trial updates, and poster presentations from 27 countries. Read more
Who is Attending
Companies, Hospitals, Clinical Centers, and Industry Organizations
Jafral (Supporter)
Cellexus (Supporter)
A&P Inphatec
Amazon
Apothekendienstleistungen
Aptar Radolfzell GmbH
ArGe Teknoloji Sanayi ve Ticaret Anonim Şirketi
A*STAR Infectious Diseases Lab
Centro de Calidad Avícola y Alimentación Animal de la Comunidad Valenciana
FagoFarma
Grachtenhaus-Apotheke e.K.
German Collection of Microorganisms and Cell Cultures GmbH
Inteliphage
Kanzlei BRENNER
Komplementäre Tiermedizin GmbH
LABOKLIN GmbH & Co. KG
Laboklin Phage Center
Laboratorios Syva
MB Pharma
Medios AG
MicrobiotiX
Nordmark Pharma
Otsuka Pharmaceutical CO.
Phagos
Poulpharm
Precise Health SA
PrecisionPhage
Qiagen
Rime Bioinformatics
Salem Microbes
State Agency of Medicines Country
TiPHAGEAcademic Hospital Bundeswehr Berlin
Center de investigación en red – Enfermedades Respiratorias
Centre hospitalier universitaire vaudois
Centre of Excellence for Biosensors, Instrumentations and Process Control
Federal research and clinical center of intensive care medicine and rehabilitology
Hannover Medical School
IIS-Fundación Jiménez Díaz and CIBERINFEC-Consorcio Centro de Investigación Biomédica en Red (CIBER) de Enfermedades Infecciosas
Jena University Hospital
Lausanne University Hospital
Ortopedska bolnišnica Valdotra
Shanghai Public Health Clinical Center
Victor Babes University of Medicine and Pharmacy Timisoara
Vivantes Klinik Bavaria Kreischa
Universities and Academic Institutions
Aristotle University of Thessaloniki
Charles University
Charité – Universitätsmedizin Berlin
Comenius University in Bratislava
Dayananda Sagar University
Delft University of Technology
Friedrich Schiller University Jena
HMU Health & Medical University Erfurt
INSERM
Institute of Pharmacology and Toxicology, Veterinary Medicine
Karadeniz Technical University
Kyorin University
Leibniz Institute DSMZ
Marmara University
Masaryk University
Max Planck Inst Molecular Genetics
Monash University
Nanyang Technological University
Rakuno Gakuen University
Recep Tayyip Erdoğan University
Stockholm University
Tel Aviv University
UCLouvain
Universidade Federal de São Paulo
Università degli Studi di Milano
Université de Paris
University of Bologna
University of California, San Diego
University of Copenhagen
University of Helsinki
University of Liverpool
University of Milan
University of Ottawa
University of Pisa
University of Roma Tor Vergata
University of Southampton
University of Warwick
Vrije Universiteit Brussel
Yale University
Phage Therapy 2024: Towards Personalized Phage Therapy
The 7th World Conference on Targeting Phage Therapy 2024 on June 20-21 at Corinthia Palace in Malta was a great success. Over 40 presentations on the latest phage research were delivered to an audience of over 100 attendees representing 35 countries. Read more.